Drug intelligence / Profile preview

sodium phosphate + polyethylene glycol 3350 + sodium sulfate + sodium bicarbonate + sodium chloride + potassium chloride

Development stage
Unknown
Lead developer
Braintree
Modality
Small Molecules
Administration
Oral
01

Overview

OSPS + Colyte refers to a combination bowel cleansing regimen consisting of Oral Sodium Phosphate Solution (OSPS) and Colyte, a polyethylene glycol-electrolyte lavage solution (PEG-ELS). This regimen is primarily indicated for colonic cleansing prior to colonoscopy or other diagnostic procedures. It combines the saline laxative properties of sodium phosphate, which induces fluid secretion into the small intestine, with the osmotic activity of PEG 3350, which promotes bowel evacuation. The combination is designed to improve patient tolerability by reducing the total volume of PEG solution required compared to standard high-volume preparations. A fixed-dose combination product containing these ingredients was previously marketed under the brand name Suclear, which was approved by the FDA in 2013 but subsequently discontinued. The use of sodium phosphate-containing preparations is associated with a risk of acute phosphate nephropathy, particularly in patients with renal impairment or those taking certain medications.

Brand names
SuclearFleet Phospho-soda
Other names
OSPS + ColyteSodium phosphate and PEG-ELS combinationOSPS-PEG

Beyond the preview

Go deeper on sodium phosphate + polyethylene glycol 3350 + sodium sulfate + sodium bicarbonate + sodium chloride + potassium chloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium phosphate + polyethylene glycol 3350 + sodium sulfate + sodium bicarbonate + sodium chloride + potassium chloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call